X-3010142-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The ENST00000381130.3(ARSH):āc.205A>Gā(p.Ile69Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000273 in 1,209,234 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 10 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000381130.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ARSH | NM_001011719.2 | c.205A>G | p.Ile69Val | missense_variant | 2/9 | ENST00000381130.3 | NP_001011719.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ARSH | ENST00000381130.3 | c.205A>G | p.Ile69Val | missense_variant | 2/9 | 1 | NM_001011719.2 | ENSP00000370522 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000152 AC: 17AN: 111979Hom.: 0 Cov.: 23 AF XY: 0.000205 AC XY: 7AN XY: 34129
GnomAD3 exomes AF: 0.0000275 AC: 5AN: 181718Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 66278
GnomAD4 exome AF: 0.0000146 AC: 16AN: 1097202Hom.: 0 Cov.: 30 AF XY: 0.00000827 AC XY: 3AN XY: 362580
GnomAD4 genome AF: 0.000152 AC: 17AN: 112032Hom.: 0 Cov.: 23 AF XY: 0.000205 AC XY: 7AN XY: 34192
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2023 | The c.205A>G (p.I69V) alteration is located in exon 2 (coding exon 2) of the ARSH gene. This alteration results from a A to G substitution at nucleotide position 205, causing the isoleucine (I) at amino acid position 69 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at